TELA Bio (TELA) Total Non-Current Liabilities (2018 - 2026)

TELA Bio has reported Total Non-Current Liabilities for 9 years, with the latest figure at $74.3 million in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 30.09% year-over-year to $74.3 million in Q2 2026; TTM through Jun 2026 was $74.3 million, a 30.09% increase from a year earlier, with the FY2025 full-year figure at $73.6 million, up 29.81% from the prior year.
• Total Non-Current Liabilities was $74.3 million for Q2 2026 at TELA Bio, up from $73.7 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $74.3 million in Q2 2026, with the low at $44.0 million in Q1 2022.
• Average Total Non-Current Liabilities over 5 years is $58.1 million, with a median of $56.3 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities soared 35.11% in 2022, then dropped 1.32% in 2024.
• Over 5 years, Total Non-Current Liabilities stood at $52.3 million in 2022, then grew by 9.87% to $57.5 million in 2023, then decreased by 1.32% to $56.7 million in 2024, then advanced by 29.81% to $73.6 million in 2025, then grew by 0.91% to $74.3 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $74.3 million (Q2 2026), $73.7 million (Q1 2026), and $73.6 million (Q4 2025), per Business Quant data.